Novocure (NASDAQ: NVCR) is presenting new data at the 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS) this week, and that helped spark a 10.5% rally in its shares today.
Novocure markets Optune, a device worn by patients with rare forms of brain cancer to disrupt cancer cell division.
IMAGE SOURCE: GETTY IMAGES.